PortalPublikationenPhase II window study on rituximab in newly diagnosed pediat...

Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.

Standard

Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. / Meinhardt, Andrea; Burkhardt, Birgit; Zimmermann, Martin; Borkhardt, Arndt; Kontny, Udo; Klingebiel, Thomas; Berthold, Frank; Janka-Schaub, Gritta; Klein, Christoph; Kabickova, Edita; Klapper, Wolfram; Attarbaschi, Andishe; Schrappe, Martin; Reiter, Alfred; Group, Berlin-Frankfurt-Münster.

in: J CLIN ONCOL, Jahrgang 28, Nr. 19, 19, 2010, S. 3115-3121.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Meinhardt, A, Burkhardt, B, Zimmermann, M, Borkhardt, A, Kontny, U, Klingebiel, T, Berthold, F, Janka-Schaub, G, Klein, C, Kabickova, E, Klapper, W, Attarbaschi, A, Schrappe, M, Reiter, A & Group, B-F-M 2010, 'Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.', J CLIN ONCOL, Jg. 28, Nr. 19, 19, S. 3115-3121. <http://www.ncbi.nlm.nih.gov/pubmed/20516455?dopt=Citation>

APA

Meinhardt, A., Burkhardt, B., Zimmermann, M., Borkhardt, A., Kontny, U., Klingebiel, T., Berthold, F., Janka-Schaub, G., Klein, C., Kabickova, E., Klapper, W., Attarbaschi, A., Schrappe, M., Reiter, A., & Group, B-F-M. (2010). Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. J CLIN ONCOL, 28(19), 3115-3121. [19]. http://www.ncbi.nlm.nih.gov/pubmed/20516455?dopt=Citation

Vancouver

Meinhardt A, Burkhardt B, Zimmermann M, Borkhardt A, Kontny U, Klingebiel T et al. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. J CLIN ONCOL. 2010;28(19):3115-3121. 19.

Bibtex

@article{8de014593c65438d86835b2d9de80007,
title = "Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.",
abstract = "The activity of rituximab in pediatric B-cell non-Hodgkin's lymphoma (B-NHL) has not yet been determined. We conducted a phase II window study to examine activity and tolerability of rituximab in newly diagnosed pediatric B-NHL.",
keywords = "Humans, Male, Female, Adolescent, Treatment Outcome, Antibodies, Monoclonal administration, dosage, Child, Child, Preschool, Infant, Antineoplastic Agents administration, Infusions, Intravenous, Antibodies, Monoclonal, Murine-Derived, Burkitt Lymphoma diagnosis, Fatigue chemically induced, Fever chemically induced, Lymphoma, B-Cell diagnosis, Lymphoma, Non-Hodgkin diagnosis, Nausea chemically induced, Humans, Male, Female, Adolescent, Treatment Outcome, Antibodies, Monoclonal administration, dosage, Child, Child, Preschool, Infant, Antineoplastic Agents administration, Infusions, Intravenous, Antibodies, Monoclonal, Murine-Derived, Burkitt Lymphoma diagnosis, Fatigue chemically induced, Fever chemically induced, Lymphoma, B-Cell diagnosis, Lymphoma, Non-Hodgkin diagnosis, Nausea chemically induced",
author = "Andrea Meinhardt and Birgit Burkhardt and Martin Zimmermann and Arndt Borkhardt and Udo Kontny and Thomas Klingebiel and Frank Berthold and Gritta Janka-Schaub and Christoph Klein and Edita Kabickova and Wolfram Klapper and Andishe Attarbaschi and Martin Schrappe and Alfred Reiter and Berlin-Frankfurt-M{\"u}nster Group",
year = "2010",
language = "Deutsch",
volume = "28",
pages = "3115--3121",
journal = "J CLIN ONCOL",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "19",

}

RIS

TY - JOUR

T1 - Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.

AU - Meinhardt, Andrea

AU - Burkhardt, Birgit

AU - Zimmermann, Martin

AU - Borkhardt, Arndt

AU - Kontny, Udo

AU - Klingebiel, Thomas

AU - Berthold, Frank

AU - Janka-Schaub, Gritta

AU - Klein, Christoph

AU - Kabickova, Edita

AU - Klapper, Wolfram

AU - Attarbaschi, Andishe

AU - Schrappe, Martin

AU - Reiter, Alfred

AU - Group, Berlin-Frankfurt-Münster

PY - 2010

Y1 - 2010

N2 - The activity of rituximab in pediatric B-cell non-Hodgkin's lymphoma (B-NHL) has not yet been determined. We conducted a phase II window study to examine activity and tolerability of rituximab in newly diagnosed pediatric B-NHL.

AB - The activity of rituximab in pediatric B-cell non-Hodgkin's lymphoma (B-NHL) has not yet been determined. We conducted a phase II window study to examine activity and tolerability of rituximab in newly diagnosed pediatric B-NHL.

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Treatment Outcome

KW - Antibodies, Monoclonal administration

KW - dosage

KW - Child

KW - Child, Preschool

KW - Infant

KW - Antineoplastic Agents administration

KW - Infusions, Intravenous

KW - Antibodies, Monoclonal, Murine-Derived

KW - Burkitt Lymphoma diagnosis

KW - Fatigue chemically induced

KW - Fever chemically induced

KW - Lymphoma, B-Cell diagnosis

KW - Lymphoma, Non-Hodgkin diagnosis

KW - Nausea chemically induced

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Treatment Outcome

KW - Antibodies, Monoclonal administration

KW - dosage

KW - Child

KW - Child, Preschool

KW - Infant

KW - Antineoplastic Agents administration

KW - Infusions, Intravenous

KW - Antibodies, Monoclonal, Murine-Derived

KW - Burkitt Lymphoma diagnosis

KW - Fatigue chemically induced

KW - Fever chemically induced

KW - Lymphoma, B-Cell diagnosis

KW - Lymphoma, Non-Hodgkin diagnosis

KW - Nausea chemically induced

M3 - SCORING: Zeitschriftenaufsatz

VL - 28

SP - 3115

EP - 3121

JO - J CLIN ONCOL

JF - J CLIN ONCOL

SN - 0732-183X

IS - 19

M1 - 19

ER -